Published in Mol Biol Cell on July 01, 2002
Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell (2009) 4.78
Identification and functional analysis of in vivo phosphorylation sites of the Arabidopsis BRASSINOSTEROID-INSENSITIVE1 receptor kinase. Plant Cell (2005) 3.48
Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. Biophys J (2007) 2.23
Structure-based view of epidermal growth factor receptor regulation. Annu Rev Biophys (2008) 1.97
Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry (2006) 1.96
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A (2012) 1.80
Ligand-induced ErbB receptor dimerization. Exp Cell Res (2008) 1.73
Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy. Biophys J (2007) 1.64
Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs. Biochemistry (2008) 1.48
Single-molecule analysis of epidermal growth factor binding on the surface of living cells. EMBO J (2006) 1.45
Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging. Proc Natl Acad Sci U S A (2011) 1.27
Regulation of the catalytic activity of the EGF receptor. Curr Opin Struct Biol (2011) 1.26
Spatio-temporal modeling of signaling protein recruitment to EGFR. BMC Syst Biol (2010) 1.17
Single-molecule imaging reveals transforming growth factor-beta-induced type II receptor dimerization. Proc Natl Acad Sci U S A (2009) 1.14
Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor. J Biol Chem (2009) 1.12
Ligand-induced EGF receptor oligomerization is kinase-dependent and enhances internalization. J Biol Chem (2010) 1.11
EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization. PLoS One (2011) 1.07
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action. Breast Cancer Res (2011) 1.06
Higher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers. Biochemistry (2008) 1.04
Probing the protein interaction network of Pseudomonas aeruginosa cells by chemical cross-linking mass spectrometry. Structure (2015) 1.03
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer. Nat Cell Biol (2016) 1.02
Visualization of BRI1 and BAK1(SERK3) membrane receptor heterooligomers during brassinosteroid signaling. Plant Physiol (2013) 1.01
Kinase-mediated quasi-dimers of EGFR. FASEB J (2010) 1.01
Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. J Biol Chem (2012) 1.01
Physical basis behind achondroplasia, the most common form of human dwarfism. J Biol Chem (2010) 0.99
EGFR juxtamembrane domain, membranes, and calmodulin: kinetics of their interaction. Biophys J (2009) 0.99
Single-molecule analysis of epidermal growth factor signaling that leads to ultrasensitive calcium response. Biophys J (2005) 0.98
Computational modeling reveals molecular details of epidermal growth factor binding. BMC Cell Biol (2005) 0.95
The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding. J Biol Chem (2011) 0.95
Affecting Rhomboid-3 function causes a dilated heart in adult Drosophila. PLoS Genet (2010) 0.93
Conformational changes accompany phosphorylation of the epidermal growth factor receptor C-terminal domain. Protein Sci (2005) 0.93
The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction. J Biol Chem (2010) 0.93
Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2008) 0.93
A view into the blind spot: solution NMR provides new insights into signal transduction across the lipid bilayer. Structure (2010) 0.89
Retracted The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility. Proc Natl Acad Sci U S A (2008) 0.89
Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. J Mol Signal (2012) 0.88
Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging. J Biol Chem (2013) 0.87
Oligomerization of DHHC protein S-acyltransferases. J Biol Chem (2013) 0.86
Mechanisms of activation of receptor tyrosine kinases: monomers or dimers. Cells (2014) 0.86
Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization. J Biol Chem (2012) 0.85
EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt. Neoplasia (2007) 0.84
Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence. Sci Rep (2012) 0.84
Asp-960/Glu-961 controls the movement of the C-terminal tail of the epidermal growth factor receptor to regulate asymmetric dimer formation. J Biol Chem (2010) 0.83
The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways. J Biol Chem (2015) 0.82
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. Oncotarget (2015) 0.82
PAMP-triggered immunity: Early events in the activation of FLAGELLIN SENSITIVE2. Plant Signal Behav (2008) 0.81
Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins. J Biol Chem (2016) 0.80
Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose angiopoietin-1. J Biol Chem (2013) 0.79
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells. Sci Rep (2014) 0.79
Evidence for intermolecular interactions between the intracellular domains of the arabidopsis receptor-like kinase ACR4, its homologs and the Wox5 transcription factor. PLoS One (2015) 0.78
Juxtamembrane contribution to transmembrane signaling. Biopolymers (2015) 0.76
APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis. Oncotarget (2016) 0.75
Three Recombinant Engineered Antibodies against Recombinant Tags with High Affinity and Specificity. PLoS One (2016) 0.75
Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro. Drug Des Devel Ther (2017) 0.75
Single particle tracking-based reaction progress kinetic analysis reveals a series of molecular mechanisms of cetuximab-induced EGFR processes in a single living cell. Chem Sci (2017) 0.75
Single-molecule imaging of EGFR signalling on the surface of living cells. Nat Cell Biol (2000) 6.63
Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem (1987) 5.57
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14
Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry (1987) 3.94
Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science (1984) 3.62
Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry (1987) 3.20
Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science (1989) 3.13
The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol (1995) 3.09
A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem (1982) 3.04
Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J Cell Biol (1995) 3.00
Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol (2001) 2.50
Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J Biol Chem (1988) 2.30
Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J (1997) 2.16
Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci U S A (1987) 2.10
Betacellulin: a mitogen from pancreatic beta cell tumors. Science (1993) 2.10
Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem (1995) 2.09
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci U S A (2001) 2.00
Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J (1989) 1.90
Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem (1995) 1.77
Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol Cell Biol (1988) 1.67
Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase. Mol Biol Cell (2000) 1.62
Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J (1989) 1.56
Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science (1996) 1.55
Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene (1997) 1.52
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim Biophys Acta (1998) 1.51
Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J Biol Chem (1991) 1.48
Receptor signaling: when dimerization is not enough. Curr Biol (1999) 1.42
Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain. J Biol Chem (1991) 1.41
A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem Biophys Res Commun (1992) 1.35
Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol Cell Biol (1998) 1.30
Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.23
Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J Biol Chem (1999) 1.21
Signal transmission by epidermal growth factor receptor: coincidence of activation and dimerization. Biochemistry (1992) 1.15
Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor. J Biol Chem (1999) 1.07
STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line. J Biol Chem (1997) 0.98
Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J Biol Chem (1995) 0.94
A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer? Biochemistry (1997) 0.86
Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions. J Virol (1996) 0.82
Oncogenic activation of the alphaPDGFR defines a domain that negatively regulates receptor dimerization. Oncogene (1997) 0.82
Protective conditioning for acute graft-versus-host disease. N Engl J Med (2005) 4.07
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2008) 2.60
Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A (2003) 2.45
Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res (2005) 1.99
Gene genealogies when the sample size exceeds the effective size of the population. Mol Biol Evol (2003) 1.79
Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection. Surg Endosc (2006) 1.58
Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res (2003) 1.57
Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci (2005) 1.55
Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci (2006) 1.55
Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol (2003) 1.51
HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases. Am J Hematol (2010) 1.46
Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leuk Lymphoma (2010) 1.41
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res (2004) 1.41
Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer (2009) 1.39
Effects of cortisol administration on hepatic circulation during brain death in rabbits. Surgery (2002) 1.38
Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol (2003) 1.36
Partial gastrectomy using natural orifice translumenal endoscopic surgery (NOTES) for gastric submucosal tumors: early experience in humans. Surg Endosc (2009) 1.32
ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct (2006) 1.30
Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun (2007) 1.27
Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res (2012) 1.25
Intra-abdominal textiloma. A retained surgical sponge mimicking a gastric gastrointestinal stromal tumor: report of a case. Surg Today (2008) 1.21
Tetraspanin protein (TSP-15) is required for epidermal integrity in Caenorhabditis elegans. J Cell Sci (2004) 1.20
Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. Int Immunol (2008) 1.20
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. Int J Hematol (2009) 1.19
Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem (2012) 1.19
Sulfated glycosaminoglycans are necessary for Nodal signal transmission from the node to the left lateral plate in the mouse embryo. Development (2007) 1.19
Feasibility of laparoscopy-assisted total gastrectomy in patients with clinical stage I gastric cancer. Gastric Cancer (2013) 1.16
Desiccation-induced structuralization and glass formation of group 3 late embryogenesis abundant protein model peptides. Biochemistry (2010) 1.16
HB-EGF promotes epithelial cell migration in eyelid development. Development (2005) 1.16
Gastric schwannomas revisited: has precise preoperative diagnosis become feasible? Gastric Cancer (2012) 1.16
Maternal heparin-binding-EGF deficiency limits pregnancy success in mice. Proc Natl Acad Sci U S A (2007) 1.15
Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem (2002) 1.13
Differentiation and proliferation of endocrine cells in the regenerating rat pancreas after 90% pancreatectomy. Arch Histol Cytol (2003) 1.13
Multiple-state reactions between the epidermal growth factor receptor and Grb2 as observed by using single-molecule analysis. Proc Natl Acad Sci U S A (2007) 1.13
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain. PLoS One (2008) 1.11
The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice. Proc Natl Acad Sci U S A (2008) 1.10
Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann Surg Oncol (2013) 1.10
Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy. Int J Clin Oncol (2007) 1.08
Host-residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol (2005) 1.08
Solitary fibrous tumor of the pleura with hemothorax at the thoracic apex. Jpn J Thorac Cardiovasc Surg (2003) 1.07
Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Int J Cancer (2009) 1.07
Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin Immunol (2012) 1.04
Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice. Immunol Lett (2002) 1.03
Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2009) 1.03
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene. Int J Clin Oncol (2009) 1.03
FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts. Proc Natl Acad Sci U S A (2006) 1.02
Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Ann Surg Oncol (2012) 1.01
HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. Cancer Res (2011) 1.01
Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF. Blood (2011) 1.01
Parasporin-1, a novel cytotoxic protein to human cells from non-insecticidal parasporal inclusions of Bacillus thuringiensis. J Biochem (2005) 1.00
Impact of KRAS and EGFR gene mutations on recurrence and survival in patients with surgically resected lung adenocarcinomas. Ann Surg Oncol (2011) 1.00
Depletion of selenoprotein GPx4 in spermatocytes causes male infertility in mice. J Biol Chem (2009) 1.00
Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures. J Cell Sci (2009) 1.00
Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study. Cancer (2012) 0.99
Prognostic impact of major receptor tyrosine kinase expression in gastric cancer. Ann Surg Oncol (2014) 0.99
Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour. Gut (2011) 0.98
Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor. Cancer Sci (2008) 0.97
Laparoscopic intragastric surgery revisited: its role for submucosal tumors adjacent to the esophagogastric junction. Surg Laparosc Endosc Percutan Tech (2012) 0.97
A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma. J Surg Oncol (2009) 0.96
Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett (2003) 0.96
Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15. J Immunol (2009) 0.96
Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor. Cancer Res (2010) 0.95
Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor. Cell Struct Funct (2006) 0.95
Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc Natl Acad Sci U S A (2013) 0.94
Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. Jpn J Thorac Cardiovasc Surg (2003) 0.94
Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem (2008) 0.94
A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells. Clin Cancer Res (2011) 0.93
ESHAP therapy effective in a patient with Langerhans cell sarcoma. Int J Hematol (2008) 0.93
Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma. J Surg Oncol (2011) 0.92
Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3. J Biochem (2013) 0.92
Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells. Cancer Sci (2010) 0.92
High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. J Surg Oncol (2015) 0.91
Beta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus. Clin Immunol (2009) 0.91
Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity. Cancer Sci (2004) 0.91
Eicosapentaenoic acid is converted via ω-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid. FASEB J (2013) 0.89
Tetraspanin is required for generation of reactive oxygen species by the dual oxidase system in Caenorhabditis elegans. PLoS Genet (2012) 0.89
Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma. Int J Cancer (2010) 0.89
The many-demes limit for selection and drift in a subdivided population. Theor Popul Biol (2004) 0.89
The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Exp Hematol (2007) 0.89
Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation. J Neurosci (2004) 0.89
Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. J Biochem (2010) 0.89
Intimal sarcoma of aortic arch treated with proton therapy following surgery. Asian Cardiovasc Thorac Ann (2008) 0.89
Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy. Br J Haematol (2011) 0.88
Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. Int J Cancer (2009) 0.87
CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells. Leuk Lymphoma (2006) 0.87
Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin. Infect Immun (2006) 0.87
c-myc induces autophagy in rat 3Y1 fibroblast cells. Cell Struct Funct (2003) 0.87
Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer. Anticancer Res (2011) 0.87
HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans. Development (2010) 0.87